Freenome, Inc. Gain (Loss) on Investments
Freenome, Inc. (FRNM) reported Gain (Loss) on Investments of -$34.10 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2026-05-13
- Freenome, Inc. gain (loss) on investments for the quarter ending 2026-03-31 was -$34.10K.
- Freenome, Inc. gain (loss) on investments for the quarter ending 2025-09-30 was $28.20K, a 98.51% increase year-over-year.
- Freenome, Inc. gain (loss) on investments for the quarter ending 2025-06-30 was -$879.00, a 112.39% decline year-over-year.
- Freenome, Inc. gain (loss) on investments for the quarter ending 2025-03-31 was -$27.40K.
| Period end | Gain (Loss) on Investments 0 month | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | -$34.10K 10-Q · filed 2026-05-13 | ||||
| 2025-09-30 | $28.20K 10-Q · filed 2025-11-13 | $27.32K derived: sum of 2 quarters · filed 2025-11-13 | -$82.00 10-Q · filed 2025-11-13 | $17.01K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-06-30 | -$879.00 10-Q · filed 2025-08-13 | -$28.28K 10-Q · filed 2025-08-13 | -$11.18K derived: sum of 3 quarters · filed 2026-05-13 | $3.02K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-03-31 | -$27.40K 10-Q · filed 2026-05-13 | -$10.30K derived: sum of 2 quarters · filed 2026-05-13 | $3.90K derived: sum of 3 quarters · filed 2026-05-13 | $11.00K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $17.09K derived: 10-K 9 month − 10-Q 6 month · filed 2025-03-19 | $31.30K derived: sum of 2 quarters · filed 2025-11-13 | $38.40K 10-K · filed 2025-03-19 | ||
| 2024-09-30 | $14.20K 10-Q · filed 2025-11-13 | $21.30K 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $7.10K 10-Q · filed 2025-08-13 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |